Rebile is the trade name, generic name of fluvoxamine maleate tablets, during the administration of occasional transient changes in liver function, can be recovered after discontinuation of the drug, standardized use of the drug is not very harmful to the liver. Adverse reactions such as nausea, vomiting, somnolence, constipation, anxiety and fatigue are common after the use of this drug, and transient hepatic function changes are occasionally seen, which can be recovered after discontinuation of the drug; patients with abnormalities of hepatic and renal function should have a lower starting dose and should be closely monitored. Fluvoxamine maleate or other excipients allergy is prohibited; prohibited with monoamine oxidase inhibitors (such as moclobemide); prohibited in lactating women. The drug is not recommended for children; elderly patients should be slowly incremental when adjusting the dose should be used with caution in patients with a history of epilepsy, the occurrence of convulsions should be immediately discontinued; patients with a history of abnormal bleeding should be used with caution; drivers or machine operators should be aware of the application of the reaction of drowsiness. Fluvoxamine maleate tablets have certain adverse reactions, it is recommended to use the drug under the guidance of a doctor, not blindly self-medication, in order to avoid adverse reactions.